Document is current
Any future updates will be listed below
-
Authors
Boy, Katharina https://orcid.org/0009-0009-9616-6278
Ohm, Niklas https://orcid.org/0009-0004-1539-5890
May, Susann https://orcid.org/0000-0003-3847-4861
Nordmann, Greta https://orcid.org/0009-0004-2046-087X
Wilson, Lynn https://orcid.org/0009-0008-4371-3373
Knitza, Johannes https://orcid.org/0000-0001-9695-0657
Heinze, Martin https://orcid.org/0000-0003-3645-1033
Gupta, Latika https://orcid.org/0000-0003-2753-2990
Muehlensiepen, Felix https://orcid.org/0000-0001-8571-7286
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Brandenburg CAMPUS GmbH
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 9 May 2025
First Online: 4 June 2025
Declarations
:
: The study was approved by IRB at Brandenburg Medical School, Germany (157102023-NMF-E). Written informed consent was obtained from all study participants. All methods were performed in accordance with relevant guidelines and regulations/declarations of Helsinki. Informed consent was obtained from all subjects and/or their legal guardian(s) for study participation. This manuscript has been compiled in accordance with the Consolidated Criteria for Reporting Qualitative Research (COREQ).
: No part of this manuscript, including text and graphics, has been copied or published elsewhere, either in whole or in part. No AI was used to generate original research content or results. The views and opinions expressed are solely those of the author and do not represent or reflect those of any affiliated institution (LG).
: KB, NO, GN, LW, JK, MH and LG declare no conflicts of interest. SM and FM have received funding from AbbVie and Novartis. LG is co-chair of EMEUNET social media and serves as social media editor for the Journal of Clinical Rheumatology.
